肽聚糖
免疫系统
胰腺癌
干细胞
癌症干细胞
生物
免疫识别
癌症研究
癌症
医学
免疫学
计算生物学
细胞生物学
生物化学
内科学
酶
作者
Juan Carlos López-Gil,Susana Garcı́a-Silva,Laura Ruíz-Cañas,Diego Navarro,Adrián Palencia‐Campos,Antonio Giráldez-Trujillo,Julie Earl,Jorge Dorado,Gonzalo Goméz-López,Ana Monfort‐Vengut,Sonia Alcalá,Matthias M. Gaida,Sandra García‐Mulero,Pablo Cabezas‐Sainz,Sandra Batres-Ramos,Emma Barreto,Patricia Sánchez-Tomero,Mireia Vallespinós,Leah Ambler,Meng‐Lay Lin
出处
期刊:Gut
[BMJ]
日期:2024-05-16
卷期号:73 (9): 1489-1508
被引量:20
标识
DOI:10.1136/gutjnl-2023-330995
摘要
Objective Pancreatic ductal adenocarcinoma (PDAC) has limited therapeutic options, particularly with immune checkpoint inhibitors. Highly chemoresistant ‘stem-like’ cells, known as cancer stem cells (CSCs), are implicated in PDAC aggressiveness. Thus, comprehending how this subset of cells evades the immune system is crucial for advancing novel therapies. Design We used the KPC mouse model ( LSL-Kras G12D/+ ; LSL-Trp53 R172H/+ ; Pdx-1-Cre ) and primary tumour cell lines to investigate putative CSC populations. Transcriptomic analyses were conducted to pinpoint new genes involved in immune evasion. Overexpressing and knockout cell lines were established with lentiviral vectors. Subsequent in vitro coculture assays, in vivo mouse and zebrafish tumorigenesis studies, and in silico database approaches were performed. Results Using the KPC mouse model, we functionally confirmed a population of cells marked by EpCAM, Sca-1 and CD133 as authentic CSCs and investigated their transcriptional profile. Immune evasion signatures/genes, notably the gene peptidoglycan recognition protein 1 (PGLYRP1), were significantly overexpressed in these CSCs. Modulating PGLYRP1 impacted CSC immune evasion, affecting their resistance to macrophage-mediated and T-cell-mediated killing and their tumourigenesis in immunocompetent mice. Mechanistically, tumour necrosis factor alpha (TNFα)-regulated PGLYRP1 expression interferes with the immune tumour microenvironment (TME) landscape, promoting myeloid cell-derived immunosuppression and activated T-cell death. Importantly, these findings were not only replicated in human models, but clinically, secreted PGLYRP1 levels were significantly elevated in patients with PDAC. Conclusions This study establishes PGLYRP1 as a novel CSC-associated marker crucial for immune evasion, particularly against macrophage phagocytosis and T-cell killing, presenting it as a promising target for PDAC immunotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI